Pfizer and BioNTech gain approval on new COVID-19 vaccine
December 2, 2020

This long-awaited moment has finally arrived! This morning, Pfizer and BioNTech’s vaccine has been approved for use in the UK as early as next week. It is the fastest vaccine ever to be developed, taking only 10 months to convert the concept into reality, a process that ordinarily takes 10 years.2

BNT162b2, which offers 95% protection has been approved by Britain for largescale immunisation against COVID-19.2,3 MHRA (Medicines and Healthcare products Regulatory Agency) put out a statement saying that they “have carried out a rigorous scientific assessment of all the available evidence of quality, safety and effectiveness” and are pleased to announce the approval of this vaccine. They also suggested that “Vaccines are the most effective way to prevent infectious diseases” saving millions of lives worldwide every year.4

40 million doses have been ordered so far and the UK’s health secretary Matt Hancock has suggested that the first 800,000 doses will be available for vaccination from next week.2 He added that the doses will be administered as quickly as they can be made, but the bulk of the vaccination process will happen next year. Once the vaccine campaign is up and running with enough doses, it is thought over a million doses could be administered each week.

Though this is a fantastic step in the right direction, we cannot afford let our guard down. Experts have made it clear that we all must stay vigilant, respect social distancing and use face masks to beat the virus.

For more information on vaccination timings, who is likely to get vaccinated first and what the efficacy values of these covid-19 vaccines actually mean, check out last weeks blog post here.

References:

  1. Picture of confetti in the sky (https://unsplash.com/photos/uW_oj3jOPRg)
  2. https://www.bbc.co.uk/news/health-55145696
  3. https://www.gov.uk/government/news/uk-authorises-pfizer-biontech-covid-19-vaccine
  4. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against

Recent Blogs

Softening of public attitude towards COVID-19 vaccines

Softening of public attitude towards COVID-19 vaccines

In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...

Growing the Product Tech Team

Growing the Product Tech Team

We are so pleased to welcome four talented individuals to our team. Through their knowledge and experience, we look forward to accelerating our AI driven data insights product aligned to the needs of our commercial marketing pharmaceutical customers. Stewart McKee -...

AstraZeneca and Oxford University gain approval on new COVID-19 vaccine

AstraZeneca and Oxford University gain approval on new COVID-19 vaccine

The UK has now approved its second vaccine for COVID-19. Last week, AstraZeneca (Pharmaceutical company) and Oxford University’s vaccine was approved for use and has since been administered to the public. From this week there will be half a million doses available for...